BioCentury
ARTICLE | Company News

JNJ acquires Egea

May 18, 2004 7:00 AM UTC

Johnson & Johnson (JNJ) acquired protein therapeutics optimization company Egea (San Diego, Calif.) for an undisclosed sum. JNJ said Egea's technology will help the drug development efforts at its Cen...